共 491 条
[11]
Sheng JF(2020)Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication Diabetes Care 101 236-548
[12]
Cai HL(2020)Diabetes patients with COVID-19 need better blood glucose management in Wuhan China Metabolism 71 539-116
[13]
Qiu YQ(2014)Resistant hypertension in patients with type 2 diabetes: clinical correlates and association with complications J Hypertens 93 543-627
[14]
Li LJ(2018)The long-term impact of renin-angiotensin system (RAS) inhibition on cardiorenal outcomes (LIRICO): a randomized controlled trial J Am Soc Nephrol 436 112-136
[15]
Zou X(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Cell 6 19840-404
[16]
Chen K(2015)Novel RAAS agonists and antagonists: clinical applications and controversies Nat Rev Endocrinol 21 234-15676
[17]
Zou J(2014)Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation Cardiovasc Res 225 618-647
[18]
Han P(2020)Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers Hypertension 481 131-374
[19]
Hao J(2019)Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure Pharmacol Rev 43 395-953
[20]
Han Z(2008)The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice Exp Physiol 8 15670-725